Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine vs BCG in Intermediate-Risk NMIBC
NCT01697306Phase 2Completed
- Sponsor
- AOU Città della Salute e della Scienza di Torino
- Start
- Sep 2006
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine in bladder cancer, sponsored by AOU Città della Salute e della Scienza di Torino. Started Sep 2006; status: completed.
02
Drugs
gemcitabine
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT01697306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01697306.